BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4926920)

  • 1. [Association of L-dopa and other therapeutic methods in treatment of parkinsonian syndromes].
    Mingrino S
    Sist Nerv; 1970; 22(2):212-5. PubMed ID: 4926920
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative value of L-dopa, amantadine, anticholinergics, and their combinations in parkinsonian syndromes].
    Ciuca I; Bulandra R; Serbanesco A; Ninosu N
    Rev Neurol (Paris); 1972 Aug; 127(2):305-8. PubMed ID: 4672049
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of a combined L-Dopa and decarboxylase inhibitor (Ro 4-4602) therapy in parkinsonism patients. Quantitative analysis of bradykinesia using reaction times].
    Kaufmann W; Butz P; Wiesendanger M
    Dtsch Z Nervenheilkd; 1969 Dec; 197(1):85-100. PubMed ID: 5364658
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method].
    Hirayama K; Uono M; Nakanishi T; Kato N; Nagao Y
    Shinkei Kenkyu No Shimpo; 1971; 15(1):267-85. PubMed ID: 4937721
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of Parkinson's syndrome with L-dopa].
    Kaeser HE; Ferel D; Wurmser P
    Schweiz Med Wochenschr; 1970 May; 100(19):805-13. PubMed ID: 4924276
    [No Abstract]   [Full Text] [Related]  

  • 6. [Attempt at treating parkinsonism with L-dopa and Artane].
    Stelmasiak Z; Lackowska H; Maksymowicz B
    Pol Tyg Lek; 1971 Aug; 26(34):1325-6. PubMed ID: 5110789
    [No Abstract]   [Full Text] [Related]  

  • 7. [Factors which influence infavourably l-dopa treatment].
    Presthus J
    Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2115-6. PubMed ID: 4590071
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of Parkinson's disease: L-dopa or stereotaxic technics?].
    Krayenbuhl H; Siegfried J
    Neurochirurgie; 1970; 16(1):71-6. PubMed ID: 4911157
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic uses and side effects of L-dopa.
    Boshes B
    Adv Intern Med; 1972; 18():219-49. PubMed ID: 4576081
    [No Abstract]   [Full Text] [Related]  

  • 10. [Parkinsonism. Therapeutic, pathophysiological, pharmacological and biochemical aspects].
    Dupont E
    Ugeskr Laeger; 1973 Jan; 135(3):116-22. PubMed ID: 4567942
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current medical treatment of Parkinsonian syndromes].
    Cincă I; Bulandra R; Serbănesco A; Ninosu N
    Rev Roum Neurol; 1973; 10(4):257-85. PubMed ID: 4767886
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of L-dopa and stereotaxic surgery in Parkinsonism].
    Sugita K; Mutsuga N; Takaoka Y; Takeda A
    No To Shinkei; 1970 Sep; 22(9):1103-8. PubMed ID: 4918927
    [No Abstract]   [Full Text] [Related]  

  • 13. [Review of current pharmacotherapy of Parkinsonism. Comprehensive review].
    Benesová O
    Cesk Neurol; 1973 May; 36(3):196-205. PubMed ID: 4574253
    [No Abstract]   [Full Text] [Related]  

  • 14. 3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease.
    Muenter MD; Dinapoli RP; Sharpless NS; Tyce GM
    Mayo Clin Proc; 1973 Mar; 48(3):173-83. PubMed ID: 4570387
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preliminary observations on the use of intravenous amantadine and of the association of oral amantadine with anticholinergic drugs and with levo-dopa in the treatment of Parkinson's disease].
    Fasano VA; Urciuoli R; Broggi G
    Minerva Med; 1970 Jul; 61(53):2895-903. PubMed ID: 5428170
    [No Abstract]   [Full Text] [Related]  

  • 16. Parkinsonism and dopa.
    N Z Med J; 1969 May; 69(444):306-7. PubMed ID: 5256210
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of parkinsonism with L-dopa].
    Presthus J
    Nord Med; 1970 Nov; 84(46):1467-8. PubMed ID: 5479940
    [No Abstract]   [Full Text] [Related]  

  • 18. [Physiopathology and symptomatology of parkinsonian movement disorders in the light of recent therapeutic progress].
    Ferrari E
    Sist Nerv; 1970; 22(2):164-74. PubMed ID: 4926919
    [No Abstract]   [Full Text] [Related]  

  • 19. L-Dopa therapy in Parkinson's disease.
    Greer M
    J Fla Med Assoc; 1970 Jun; 57(6):23-7. PubMed ID: 4392779
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of 12 months treatment with L-DOPA of patients with Parkinson's disease].
    van der Drift JH
    Ned Tijdschr Geneeskd; 1972 Nov; 116(48):2185-93. PubMed ID: 4639073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.